If the inflammatory stromal microenvironment is responsible for upregulation of COX-2 in the pancreatic cancer cells, then it may also be responsible for the upregulation of the SCFβTRCP proteasome, which leads to increased degradation and loss of MTSS1 expression. The gene discussed is PTGS2; the disease is familial pancreatic carcinoma.